Comments
Loading...
Inventiva (IVA) Forecast
NewsEarningsInventiva (IVA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestInventiva (NASDAQ:IVA) Stock Quotes, Forecast and News Summary
Inventiva Stock (NASDAQ: IVA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Inventiva (IVA) stock?
You can purchase shares of Inventiva (NASDAQ:IVA) through any online brokerage.
Who are Inventiva (IVA) competitors?
Other companies in Inventiva’s space includes: Macrogenics (NASDAQ:MGNX), Zentalis Pharma (NASDAQ:ZNTL), Adaptimmune Therapeutics (NASDAQ:ADAP), Genelux (NASDAQ:GNLX) and RAPT Therapeutics (NASDAQ:RAPT).
What is the forecast, or price target, for Inventiva (IVA) stock?
Inventiva has a consensus price target of $12.67.
What is the current price for Inventiva (IVA)?
The stock price for Inventiva (NASDAQ: IVA) is $3.162 last updated February 26, 2025 at 9:45 AM EST.
Does Inventiva (IVA) pay a dividend?
There are no upcoming dividends for Inventiva.
When is Inventiva (NASDAQ:IVA) reporting earnings?
Inventiva’s FY earnings are confirmed for Wednesday, March 26, 2025.
Is Inventiva (IVA) going to split?
There is no upcoming split for Inventiva.
What sector and industry does Inventiva (IVA) operate in?
Inventiva is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.